1
|
Lewis JJ and Brennan MF: Soft tissue
sarcomas. Curr Probl Surg. 33:817–872. 1996. View Article : Google Scholar : PubMed/NCBI
|
2
|
Karakousis CP, Gerstenbluth R, Kontzoglou
K and Driscoll DL: Retroperitoneal sarcomas and their management.
Arch Surg. 130:1104–1109. 1995. View Article : Google Scholar : PubMed/NCBI
|
3
|
Windham TC and Pisters PW: Retroperitoneal
sarcomas. Cancer Control. 12:36–43. 2005.PubMed/NCBI
|
4
|
Heslin MJ, Lewis JJ, Nadler E, Newman E,
Woodruff JM, Casper ES, Leung D and Brennan MF: Prognostic factors
associated with long-term survival for retroperitoneal sarcoma:
Implications for management. J Clin Oncol. 15:2832–2839.
1997.PubMed/NCBI
|
5
|
Jenkins MP, Alvaranga JC and Thomas JM:
The management of retroperitoneal soft tissue sarcomas. Eur J
Cancer 32A. 622–626. 1996. View Article : Google Scholar
|
6
|
Jaques DP, Coit DG, Hajdu SI and Brennan
MF: Management of primary and recurrent soft-tissue sarcoma of the
retroperitoneum. Ann Surg. 212:51–59. 1990. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lewis JJ, Leung D, Woodruff JM and Brennan
MF: Retroperitoneal soft-tissue sarcoma: Analysis of 500 patients
treated and followed at a single institution. Ann Surg.
228:355–365. 1998. View Article : Google Scholar : PubMed/NCBI
|
8
|
McGrath PC: Retroperitoneal sarcomas.
Semin Surg Oncol. 10:364–368. 1994. View Article : Google Scholar : PubMed/NCBI
|
9
|
Dziewirski W, Rutkowski P, Nowecki ZI,
Salamacha M, Morysiński T, Kulik A, Kawczyńska M, Kasprowicz A,
Lyczek J and Ruka W: Surgery combined with intraoperative
brachytherapy in the treatment of retroperitoneal sarcomas. Ann
Surg Oncol. 13:245–252. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Classen J, Hehr T, Lamprecht U, Zumbrägel
A, Bamberg M and Budach W: Hyperfractionated 192Ir brachytherapy
for recurrent retroperitoneal sarcoma: A technique for delivery of
local tumor boost dose. Strahlenther Onkol. 179:118–122. 2003.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Strauss DC, Hayes AJ and Thomas JM:
Retroperitoneal tumours: Review of management. Ann R Coll Surg
Engl. 93:275–280. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Kumar PP and Good RR: Interstitial 125I
implantation in the retreatment of retroperitoneal soft tissue
sarcoma. Report of a case. Acta Radiol Oncol. 25:37–39. 1986.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Li Y, Wang Y, Liu B, Li Z and Wang W:
(125)I brachytherapy seeds implantation for inoperable low-grade
leiomyosarcoma of inferior vena cava. Korean J Radiol. 14:278–282.
2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Chen ME, Zhang B and Li HP: PET/CT-Guided
radioactive 125I seeds implanted in retroperitoneal sarcoma. Guang
Dong Yi Xue. 33:32012.(In Chinese).
|
15
|
Eisenhauer E, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Li Y, Wang Y, Liu B, Li Z and Wang W:
125I Brachytherapy Seeds Implantation for Inoperable
Low-Grade Leiomyosarcoma of Inferior Vena Cava. Korean J Radiol.
14:278–282. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Neuhaus SJ, Barry P, Clark MA, Hayes AJ,
Fisher C and Thomas JM: Surgical management of primary and
recurrent retroperitoneal liposarcoma. Br J Surg. 92:246–252. 2005.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Clark MA, Fisher C, Judson I and Thomas
JM: Soft-tissue sarcomas in adults. N Engl J Med. 353:701–711.
2005. View Article : Google Scholar : PubMed/NCBI
|
19
|
Mullinax JE, Zager JS and Gonzalez RJ:
Current diagnosis and management of retroperitoneal sarcoma. Cancer
Control. 18:177–187. 2011.PubMed/NCBI
|
20
|
Bonvalot S, Rivoire M, Castaing M,
Stoeckle E, Le Cesne A, Blay JY and Laplanche A: Primary
retroperitoneal sarcomas: A multivariate analysis of surgical
factors associated with local control. J Clin Oncol. 27:31–37.
2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
D'Adamo DR: Appraising the current role of
chemotherapy for the treatment of sarcoma. Semin Oncol. 38:(Suppl
3). S19–S29. 2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Adjuvant chemotherapy for localised
resectable soft-tissue sarcoma of adults, . Meta-analysis of
individual data. Sarcoma Meta-analysis Collaboration. Lancet.
350:1647–1654. 1997.PubMed/NCBI
|
23
|
Lewis JJ and Benedetti F: Adjuvant therapy
for soft tissue sarcomas. Surg Oncol Clin N Am. 6:847–862.
1997.PubMed/NCBI
|
24
|
Hines OJ, Nelson S, Quinones-Baldrich WJ
and Eilber FR: Leiomyosarcoma of the inferior vena cava: Prognosis
and comparison with leiomyosarcoma of other anatomic sites. Cancer.
85:1077–1083. 1999. View Article : Google Scholar : PubMed/NCBI
|
25
|
Ryder SD: British Society of
Gastroenterology: Guidelines for the diagnosis and treatment of
hepatocellular carcinoma (HCC) in adults. Gut. 52:(Suppl 3).
iii1–iii8. 2003. View Article : Google Scholar : PubMed/NCBI
|
26
|
Imai Y, Habe K, Imada M, Hakamada A, Isoda
KI, Yamanishi K, Uchida A and Mizutani H: A case of a large
dermatofibrosarcoma protuberans successfully treated with
radiofrequency ablation and transcatheter arterial embolization. J
Dermatol. 31:42–46. 2004. View Article : Google Scholar : PubMed/NCBI
|
27
|
Chu JP, Chen W, Li JP, Zhuang WQ, Huang
YH, Huang ZM and Yang JY: Clinicopathologic features and results of
transcatheter arterial chemoembolization for osteosarcoma.
Cardiovasc Intervent Radiol. 30:201–206. 2007. View Article : Google Scholar : PubMed/NCBI
|
28
|
Avritscher R and Javadi S: Transcatheter
intra-arterial limb infusion for extremity osteosarcoma: Technical
considerations and outcomes. Tech Vasc Interv Radiol. 14:124–128.
2011. View Article : Google Scholar : PubMed/NCBI
|
29
|
Winkler K, Bielack S, Delling G,
Salzer-Kuntschik M, Kotz R, Greenshaw C, Jürgens H, Ritter J,
Kusnierz-Glaz C and Erttmann R: Effect of intraarterial versus
intravenous cisplatin in addition to systemic doxorubicin,
high-dose methotrexate, and ifosfamide on histologic tumor response
in osteosarcoma (study COSS-86). Cancer. 66:1703–1710. 1990.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Zhao M, Li X, Wang J, Li W and Huang Z:
Retroperitoneal schwannoma treated with percutaneous computed
tomography-guided radiofrequency ablation. J Neurosurg Spine.
17:173–176. 2012. View Article : Google Scholar : PubMed/NCBI
|
31
|
Shariat SF, Raptidis G, Masatoschi M,
Bergamaschi F and Slawin KM: Pilot study of radiofrequency
interstitial tumor ablation (RITA) for the treatment of
radio-recurrent prostate cancer. Prostate. 65:260–267. 2005.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Keil S, Bruners P, Brehmer B and Mahnken
AH: Percutaneous radiofrequency ablation for treatment of recurrent
retroperitoneal liposarcoma. Cardiovasc Intervent Radiol. 31:(Suppl
2). S213–S216. 2008. View Article : Google Scholar : PubMed/NCBI
|
33
|
Nath R: Response to “Comments on
‘Dosimetry of interstitial brachytherapy sources: Recommendations
of the AAPM Radiation Therapy Committee Task Group No. 43’”. [Med.
Phys. 22, 209–234 (1995)]. Med Phys. 22:209–234. 1995. View Article : Google Scholar : PubMed/NCBI
|
34
|
Stone NN and Stock RG: Complications
following permanent prostate brachytherapy. Eur Urol. 41:427–433.
2002. View Article : Google Scholar : PubMed/NCBI
|
35
|
Sloboda RS and Menon GV: Experimental
determination of the anisotropy function and anisotropy factor for
model 6711 I-125 seeds. Med Phys. 27:1789–1799. 2000. View Article : Google Scholar : PubMed/NCBI
|
36
|
Nickers P, Thissen B, Jansen N and
Deneufbourg JM: 192Ir or 125I prostate brachytherapy as a boost to
external beam radiotherapy in locally advanced prostatic cancer: A
dosimetric point of view. Radiother Oncol. 78:47–52. 2006.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Dutreix A and Wambersie A: Letter:
Specification of gamma-ray brachytherapy sources. Br J Radiol.
48:1034–1035. 1975. View Article : Google Scholar : PubMed/NCBI
|
38
|
Zhang P and Li HP: Application of
radioactive 125I seeds in abdominal malignant solid
tumors. Yingxiang Zhenduan Yu Jieru Fangshexue. 20:313–316.
2011.(In Chinese).
|
39
|
Holloway CL, Delaney TF, Alektiar KM,
Devlin PM, O'Farrell DA and Demanes DJ: American Brachytherapy
Society (ABS) consensus statement for sarcoma brachytherapy.
Brachytherapy. 12:179–190. 2013. View Article : Google Scholar : PubMed/NCBI
|